All articles by Umesh Ellichipuram

Umesh Ellichipuram

Avacta’s AffiDX rapid antigen test detects new Covid-19 variants

UK-based Avacta Group has confirmed that its AffiDX SARS-CoV-2 rapid antigen lateral flow test can detect the dominant new variants of the coronavirus and the original strain.

Illumina and R-Pharm receive device registration for sequencing platforms

Illumina and R-Pharm have obtained medical device registration for two complete in vitro diagnostic (IVD) sequencing platforms in Russia.

Co-Diagnostics develops new at-home Covid-19 testing platform

Co-Diagnostics has developed a new point-of-care, at-home PCR testing platform to detect Covid-19 and other diseases using CoPrimer technology.

GLCM develops SARS-CoV-2 Insta-Test device for Covid-19

GLC Medical (GLCM) has developed the SARS-CoV-2 Insta-Test, which delivers the results in less than 15 seconds.

Olympus exercises option to acquire Israel’s Medi-Tate

Olympus has exercised its option to acquire Israeli medical device company Medi-Tate to drive growth in its urology business and expand minimally invasive treatment product portfolio.

UK opens new walk-through Covid-19 testing centre in Edinburgh

The Government of UK has opened a new walk-through testing centre for Covid-19 in Niddrie, Edinburgh.

CityHealth launches new in-home test kit for Covid-19

Healthcare clinic CityHealth Urgent Care in the US has launched a new in-home test kit for Covid-19 patients to conduct tests in their own homes.

Axonics acquires urethral bulking agent Bulkamid

Axonics Modulation Technologies has acquired UK-based Contura and its lead product Bulkamid, a urethral bulking agent used in the treatment of female stress urinary incontinence (SUI).

LabCorp unveils new antigen test for Covid-19

US-based life sciences company LabCorp has announced the availability of a new high-sensitivity antigen test to screen for active Covid-19 infection.

Kroger to offer at-home Covid-19 antigen test kit to patients in US

Kroger Health has collaborated with Gauss to provide a smartphone-enabled, at-home Covid-19 rapid antigen test kit to patients in the US.